Changsatja, Supitchaya, Chayanis Kositamongkol, Lucksamon Thamlikitkul, Pochamana Phisalprapa, and Touchanun Komonpaisarn. “COST-EFFECTIVENESS ANALYSIS OF ADJUVANT OSIMERTINIB IN RESECTED EGFR-MUTATED EARLY-STAGE NON-SMALL CELL LUNG CANCER IN THAILAND”. Proceedings of the International Conference on Public Health 9, no. 1 (January 23, 2025): 45–67. Accessed January 31, 2025. http://tiikmpublishing.com/proceedings/index.php/icoph/article/view/1543.